Hypothesis: Taurine therapy of nephropathic cystinosis may correct the deficiencies of cysteamine therapy. [PDF]
Thoene JG.
europepmc +1 more source
Amino Compound-Synthesized Gold Nanoparticles for SARS-CoV-2 Antigen Delivery. [PDF]
Rego LS +7 more
europepmc +1 more source
Biofilm- and Spore-Disruptive Star-Shaped Poly(l-lysine)/Hyaluronic Acid Microgels for Targeted Oral Therapy of <i>Clostridioides difficile</i> Infection. [PDF]
Lin IF +8 more
europepmc +1 more source
The Role of the Cysteamine Dioxygenase (ADO) Gene in Atopic Dermatitis. [PDF]
Wang S +9 more
europepmc +1 more source
Vanin-1 deficiency enhances host tolerance to influenza infection by modulating cellular redox status. [PDF]
Joo JS +6 more
europepmc +1 more source
Biomarker potential of vanin-1-derived pantothenic acid in diabetes and its associated cardiovascular complications. [PDF]
Shoura NK +4 more
europepmc +1 more source
The Use of a Viscous Cysteamine Eyedrop in a Belgian Cohort: Early 3-Year Results. [PDF]
Matthys E +3 more
europepmc +1 more source
Despite the high aqueous solubility of cysteamine, its unpleasant organoleptic properties, hygroscopicity, instability in solutions, and poor pharmacokinetic profile are the main drawbacks that limit its use for medical and cosmetic purposes. In this study, cysteamine-loaded liposomes were prepared using the ethanol injection method.
Hélène Greige, Catherine Charcosset
exaly +5 more sources
Related searches:
Publisher Summary This chapter discusses about cysteamine and cystamine. Cysteamine (2-aminoethanethiol) is formed in mammalian tissues by the enzymatic hydrolysis of pantetheine, and has the role in the biosynthesis of hypotaurine. Cysteamine has been used therapeutically to treat cystinosis and sickle cell anemia, and has been used as a protective ...
M W, Duffel, D J, Logan, D M, Ziegler
openaire +2 more sources

